These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32143897)

  • 1. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
    Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
    von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
    JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
    Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
    Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
    Kok MM; von Birgelen C; Sattar N; Zocca P; Löwik MM; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Kant GD; Doelman C; Tjon Joe Gin M; Stoel MG; van Houwelingen G; Linssen GCM; IJzerman MJ; Doggen CJM; van der Heijden LC
    EuroIntervention; 2018 Oct; 14(9):e1049-e1056. PubMed ID: 29313817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia.
    Cui K; Yin D; Song W; Wang H; Zhu C; Feng L; Li J; Jia L; Lu Y; Zhang R; Shi B; Song Y; Fu R; Dou K
    Eur J Prev Cardiol; 2023 Oct; 30(14):1418-1426. PubMed ID: 36987575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis.
    Zhao Y; Guo M; Shi G
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
    Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
    Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study.
    Farhan S; Redfors B; Maehara A; McAndrew T; Ben-Yehuda O; De Bruyne B; Mehran R; Giustino G; Kirtane AJ; Serruys PW; Mintz GS; Stone GW
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):733-741. PubMed ID: 29055637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials.
    Jorda A; Hengstenberg C; Lang IM; Kautzky-Willer A; Harreiter J; Zeitlinger M; Jilma B; Gelbenegger G
    Cardiovasc Diabetol; 2024 May; 23(1):176. PubMed ID: 38769562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population.
    Nakagami T; Tanaka Y; Oya J; Kurita M; Isago C; Hasegawa Y; Ito A; Hirota N; Tsuzura R; Uchigata Y
    Prim Care Diabetes; 2016 Dec; 10(6):407-414. PubMed ID: 27515716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
    Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
    Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.